# Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

> **NCT01501461** · NA · WITHDRAWN · sponsor: **Ageless Regenerative Institute**

## Conditions studied

- Frailty Syndrome

## Interventions

- **PROCEDURE:** Harvesting and implantation of stem cells

## Key facts

- **NCT ID:** NCT01501461
- **Lead sponsor:** Ageless Regenerative Institute
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-05-01
- **Primary completion:** 2017-05-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company dissolved
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01501461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01501461, "Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01501461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*